MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Home-based titration with Duodenal infusion of Levodopa in People with Parkinson’s disease: an observational feasibility study

    B. Biering-Sørensen, N. Nielsen, A. Isenberg, L. Olsen, M. Javidi, J. Vilhelmsen, M. Møller, M. Olsen, J. Clausen, T. Thomsen (Glostrup, Denmark)

    Objective: Primary objectives were to assess the feasibility and safety of LCIG home titration with use of telemedicine-assisted (TM) technology, and  patient/caregivers satisfaction. Secondly, to…
  • 2023 International Congress

    Network localization of limb ataxia

    J. Pullinen, O. Liesmäki, O. Likitalo, A. Bellmunt Gil, J. Aaltonen, E. Mäkinen, E. Ellis, P. Ylikotila, J. Joutsa (Turku, Finland)

    Objective: To identify the neural substrates of limb ataxia caused by stroke lesions. Background: Ataxia is a neurological sign defined by incoordination of voluntary movements.…
  • 2023 International Congress

    Mesencephalic neuroglial cyst can produce clinical manifestations and a metabolic [18F] FDG PET pattern mimicking a Progressive Supranuclear Palsy Syndrome

    C. Espinoza-Vinces, V. Betech-Antar, A. Atorrasagasti, S. Solís-Barquero, C. Arrondo, G. Montoya, G. Martí-Andrés, MR. García-Eulate, J. Arbizu, MR. Luquin (Pamplona, Spain)

    Objective: To describe the clinical manifestations and structural and functional neuroimaging findings in a patient with a left mesencephalic neuroglial cyst, resembling a PSP. Background:…
  • 2023 International Congress

    Motor function in Parkinson´s disease during 16h treatment with intravenously (DIZ101), subcutaneously (DIZ102), or intestinally (LCIG) infused levodopa

    F. Bergquist, M. Ehrnebo, D. Nyholm, A. Johansson, F. Lundin, P. Odin, P. Svenningsson, N. Dizdar, E. Eriksson (Gothenburg, Sweden)

    Objective: To compare the effect of intravenous (DIZ101) and subcutaneous (DIZ102) continuous 16h infusion of a continuously buffered acidic levodopa/carbidopa solution with levodopa/carbidopa intestinal gel…
  • 2023 International Congress

    Circadian rhythm and adaptive deep brain stimulation in essential tremor

    J. Yu, L. Fanty, T. Stiep, J. Cagle, N. Geigel, A. Gunduz, C. de Hemptinne (Gainesville, USA)

    Objective: We aim to develop a closed-loop adaptive deep brain stimulation (aDBS) system that turns DBS off based on the real-time detection of sleep using…
  • 2023 International Congress

    Repetitive trans-spinal magnetic stimulation and kinesiotherapy could reduce motor and gait symptoms in patients with neurodegenerative ataxia?

    C. Souza, L. Lopes, J. Oliveira, S. Casagrande, C. Tanaka, E. Barbosa, R. Cury (Sao Paulo, Brazil)

    Objective: To investigate whether a 1-week treatment with repetitive trans-spinal magnetic stimulation (rTSMS) combined with kinesiotherapy could reduce motor and gait symptoms in patients with…
  • 2023 International Congress

    Analysis of α-Synuclein Seed Amplification Assay in Carriers of GBA and LRRK2 Pathogenic Variants

    K. Fraser, A. Mirelman, O. Mabrouk, N. Omer, L. Concha-Marambio, T. Gurevich, A. Bar Shira, M. Gana-Weisz, O. Goldstein, A. Orr-Urtreger, M. Kestenbaum, J. Cedarbaum, T. Dam, J. Shirvan, N. Giladi, D. Graham, R. Alcalay, A. Thaler (Cambridge, USA)

    Objective: To assess α-synuclein seed amplification assay (αS-SAA) in cerebrospinal fluid (CSF) from a cohort of PD patients and non-manifesting carriers (NMCs) of pathogenic GBA…
  • 2023 International Congress

    Detection and classification of GBA variants PD-related: is there sex unbalance?

    C. Reale, C. Panteghini, I. Colangelo, M. Suerz, R. Cilia, R. Eleopra, B. Garavaglia, F. Invernizzi (Milan, Italy)

    Objective: This study aims to classify GBA variants detected in the Genetic Movement Disorders Laboratory (GMDL) of the Neurological Institute “Carlo Besta” in Milan over…
  • 2023 International Congress

    Testing the applicability of the dysarthria analyzer to detect levodopa effects on speech in a German cohort of people with Parkinson’s disease

    T. Thies, J. Schreen, H. Jergas, M. Barbe (Cologne, Germany)

    Objective: To test the applicability of “the dysarthria analyzer” in a levodopa challenge test to determine short term effects of levodopa on acoustic speech parameters.…
  • 2023 International Congress

    Clinical and radiological gender differences in Parkinson’s disease

    G. Martí-Andrés, E. Prieto-Azcarate, CA. Espinoza-Vinces, M. Riverol, S. Meles, KL. Leenders, P. Tomse, M. Perovnik, M. Trost, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)

    Objective: To assess clinical and brain metabolic gender differences in a cohort of patients with PD Background: Many studies have elucidated gender-related clinical differences in…
  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley